Cingulate develops once-a-day ADHD and anxiety medicines using its proprietary drug delivery platform. It last closed at $4.72 on Nov 17, up 25.87% on the day. The average 12-month price target from 2 analysts is $26.50 (+461.4% from the last close), with a high of $44.00 and a low of $9.00.
Only 2 firms rated CING in the past 90 days, not enough for a consensus
Average 12-month target
$26.50
▲ 461.4% upside
Based on 2 analysts who set a price target on CING in the past 90 days. The average target is $26.50, with a high of $44.00 and a low of $9.00, compared with the last close of $4.72.
Low $9.00Avg $26.50High $44.00
Blue marker: last close $4.72
Highest target$44.00
Average target$26.50
Lowest target$9.00
Latest rating changes
Roth CapitalReiterated
Aug 24Buy$9
Ascendiant CapitalTarget lowered
Aug 20Buy$52 → $44
Ascendiant CapitalMaintained
Jun 8Buy$52
HC Wainwright & Co.Reiterated
May 26Buy$20
Date
Firm
Action
Rating
Price target
Aug 24
Roth Capital
Reiterated
Buy
$9
Aug 20
Ascendiant Capital
Target lowered
Buy
$52 → $44
Jun 8
Ascendiant Capital
Maintained
Buy
$52
May 26
HC Wainwright & Co.
Reiterated
Buy
$20
Loading…
Technical Analysis
CING · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 14% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 51). The nearest support is the 20 day average at $4.71, and the nearest resistance the 50 day average at $4.82.
Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityNormal, 8.3%/day
Key levels
$11.8952 week high+151.9%
$5.37200 day average+13.8%
$5.08Pivot R1+7.6%
$4.94100 day average+4.7%
$4.84Swing high (Nov 10)+2.5%
$4.8250 day average+2.1%
$4.72Last close
$4.7120 day average−0.2%
$4.71Swing low (Aug 14)−0.2%
$4.57Pivot−3.2%
$4.21Pivot S1−10.8%
$3.1652 week low−33.1%
Indicators
RSI (14)
51.32
Middle of its range
Neutral
MACD
-0.14
Below its signal line
Bearish
Stochastic
26.9
Middle of its range
Neutral
ADX (14)
17.3
No clear trend
Williams %R
-32.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-30.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.0%
Change over 10 sessions
Bearish
ATR (14)
$0.39
Typical daily range, 8.3% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumFading
StretchNormal
VolatilityNormal, 17.3%/day
Key levels
$11.8952 week high+151.9%
$5.37200 day average+13.8%
$5.08Pivot R1+7.6%
$4.94100 day average+4.7%
$4.84Swing high (Nov 10)+2.5%
$4.8250 day average+2.1%
$4.72Last close
$4.7120 day average−0.2%
$4.71Swing low (Aug 14)−0.2%
$4.57Pivot−3.2%
$4.21Pivot S1−10.8%
$3.1652 week low−33.1%
Indicators
RSI (14)
47.89
Middle of its range
Neutral
MACD
-0.15
Below its signal line
Bearish
Stochastic
21.4
Middle of its range
Neutral
ADX (14)
14.8
No clear trend
Williams %R
-53.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-108.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−6.0%
Change over 10 sessions
Bearish
ATR (14)
$0.81
Typical daily range, 17.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for CING
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CING did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CING usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CING has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CING is in one of them and how their past CING trades turned out.
Cingulate is a biopharmaceutical company based in Kansas City, Kansas. It uses its proprietary Precision Timed Release drug delivery platform to develop medicines that release doses at set times, so patients can take them one time a day. Its lead candidate, CTx-1301, is a stimulant for attention deficit hyperactivity disorder and is under review by the U.S. Food and Drug Administration. The company is also developing a buspirone tablet for anxiety, with patients, physicians and payers as its intended users.